{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:06:32Z","timestamp":1778857592131,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1054\/blre.1999.0116","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:24Z","timestamp":1032447324000},"page":"185-204","source":"Crossref","is-referenced-by-count":36,"title":["Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand\u2019s disease"],"prefix":"10.1054","volume":"13","author":[{"given":"E.J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/blre.1999.0116_RF1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s Disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/blood.V84.3.676.676","article-title":"Commentary: A new classification for von Willebrand Disease","volume":"84","author":"Sadler","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand Disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haem"},{"key":"10.1054\/blre.1999.0116_RF4","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1016\/S0021-9258(18)54418-5","article-title":"Review: Von Willebrand Factor","volume":"266","author":"Sadler","year":"1991","journal-title":"J. Biol Chem"},{"key":"10.1054\/blre.1999.0116_RF5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.me.37.020186.001105","article-title":"von Willebrand factor and platelet function","volume":"37","author":"Moroose","year":"1986","journal-title":"Ann Rev Med"},{"key":"10.1054\/blre.1999.0116_RF6","series-title":"Blood Coagulation and Haemostasis","first-page":"135","article-title":"The investigation of factor VIII deficiency","author":"Giddings","year":"1985"},{"key":"10.1054\/blre.1999.0116_RF7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0038-1642669","article-title":"Structure-function relationship of the A1 domain of von Willebrand factor","volume":"74","author":"Girma","year":"1995","journal-title":"Thromb Hamost"},{"key":"10.1054\/blre.1999.0116_RF8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09537109009005485","article-title":"The interaction of von Willebrand factor and the platelet glycoprotein Ib-IX complex","volume":"1","author":"Booth","year":"1990","journal-title":"Platelets"},{"key":"10.1054\/blre.1999.0116_RF9","unstructured":"Guidelines for the diagnosis and management of von Willebrand Disease. Prepared by the Von Willebrand Working Party of the United Kingdom Haemophilia Centre Directors\u2019 Organisation. 1995"},{"key":"10.1054\/blre.1999.0116_RF10","first-page":"161","article-title":"Molecular mechanism and classification of von Willebrand disease","volume":"161","author":"Sadler","year":"1995","journal-title":"Thromb Haemostas"},{"key":"10.1054\/blre.1999.0116_RF11","unstructured":"Sadler, J. E. Foster, P. A. George, J. N. Haemostasis\/Platelets. Haematology-1996, The Education Program of the American Society of Hematology, J. R. McArthur, 79, 94"},{"key":"10.1054\/blre.1999.0116_RF12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00313029700169365","article-title":"Laboratory assays for von Willebrand Factor: Relative contribution to the diagnosis of von Willebrand\u2019s disease","volume":"29","author":"Favaloro EJ and Koutts","year":"1997","journal-title":"Pathology"},{"key":"10.1054\/blre.1999.0116_RF13","first-page":"pp45","article-title":"von Willebrand\u2019s Disease","author":"Brown","year":"1996","journal-title":"Check Sample. Clinical Haematology No. CH 96\u20134 (CH-14). American Society of Clinical Pathologists"},{"key":"10.1054\/blre.1999.0116_RF14","first-page":"50","article-title":"von Willebrand factor: its function and its measurement in the laboratory","volume":"52","author":"Fleming","year":"1995","journal-title":"Br J Biomed Sci"},{"key":"10.1054\/blre.1999.0116_RF15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2257.1998.00115.x","article-title":"Review: Laboratory methods for the genetic diagnosis of bleeding disorders","volume":"20","author":"Goodeve","year":"1998","journal-title":"Clin Lab Haem"},{"key":"10.1054\/blre.1999.0116_RF16","article-title":"von Willebrand factor (VWF) database","author":"Ginsburg","year":"1999","journal-title":"Internet access using \u2018http:\/\/mmg2.im.med.umich.edu\/VWF\/\u2019; last accessed by author on 24th June,"},{"key":"10.1054\/blre.1999.0116_RF17","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.V79.10.2507.bloodjournal79102507","article-title":"Review: Molecular genetics of von Willebrand Disease","volume":"79","author":"Ginsburg","year":"1992","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0038-1651576","article-title":"Von Willebrand Disease: A database of point mutations, insertions, and deletions","volume":"69","author":"Ginsburg","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.1999.0116_RF19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0038-1651577","article-title":"A database of polymorphisms in the Von Willebrand factor gene and pseudogene","volume":"69","author":"Sadler","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.1999.0116_RF20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V60.3.790.790","article-title":"Platelet-Type von Willebrand\u2019s disease: Characterisation of a new bleeding disorder","volume":"60","author":"Miller","year":"1982","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand\u2019s disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<139::AID-AJH7>3.0.CO;2-Y","article-title":"Acquired von Willebrand\u2019s disease: A concise review","volume":"54","author":"Rinder","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.1999.0116_RF23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.1999.01360.x","article-title":"Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus","volume":"105","author":"Viallard","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.1999.0116_RF24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<151::AID-AJH13>3.0.CO;2-J","article-title":"Idiopathic immune-mediated acquired von Willebrand\u2019s disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor","volume":"60","author":"Alhumood","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.1999.0116_RF25","first-page":"3373","article-title":"Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen","volume":"10","author":"van Genderen","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V67.2.465.465","article-title":"DDAVP in Type IIa von Willebrand\u2019s disease","volume":"67","author":"Gralnick","year":"1986","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF27","series-title":"Annals of New York Academy of Sciences","first-page":"71","article-title":"Vasopressin analogues: Their role in disorders of haemostasis","author":"Mannucci","year":"1987"},{"key":"10.1054\/blre.1999.0116_RF28","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood.V72.5.1449.1449","article-title":"Desmopressin: A nontransfusional form of treatment for congenital and acquired bleeding disorders","volume":"72","author":"Mannuci","year":"1988","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0268-960X(91)90032-8","article-title":"Clinical indications for Desmopressin (DDAVP) in congenital and acquired von Willebrand disease","volume":"5","author":"Rodeghiero","year":"1991","journal-title":"Blood Reviews"},{"key":"10.1054\/blre.1999.0116_RF30","first-page":"276","article-title":"Desmopressin: a nontransfusional treatment of haemophilia and von Willebrand disease","volume":"22","author":"Mannucci","year":"1992","journal-title":"Haemostasis"},{"key":"10.1054\/blre.1999.0116_RF31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ajcp\/112.5.712","article-title":"Laboratory testing, diagnosis and management of von Willebrand\u2019s disease: Current practice in Australasia","volume":"112","author":"Favaloro","year":"1999","journal-title":"American Journal of Clinical Pathology,"},{"key":"10.1054\/blre.1999.0116_RF32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post-DDAVP thrombocytopaenia in Type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation","volume":"81","author":"Casonato","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.1999.0116_RF33","unstructured":"Favaloro, E. J. (1994). Review: Assessment of haemostatic function: Follow up evaluation of abnormal \u2018screening\u2019 coagulation tests and possible outcomes. Australian Journal of Medical Science, 15, 39, 45"},{"key":"10.1054\/blre.1999.0116_RF34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0268-960X(05)80014-1","article-title":"Evaluation of mild bleeding disorders and easy bruising","volume":"8","author":"Sham","year":"1994","journal-title":"Blood Reviews"},{"key":"10.1054\/blre.1999.0116_RF35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000441-199808000-00002","article-title":"Congenital disorders of platelet function: Disorders of signal transduction and secretion","volume":"316","author":"Rao","year":"1998","journal-title":"Amer J Med Sci"},{"key":"10.1054\/blre.1999.0116_RF36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/00313028509084769","article-title":"Clinching the diagnosis: Assessment of hemostatic function","volume":"17","author":"Koutts","year":"1985","journal-title":"Pathology"},{"key":"10.1054\/blre.1999.0116_RF37","unstructured":"Favaloro, E. J. Grispo, L. (1994). Comparative evaluation of 17 commercial APTT reagents. Australian Journal of Medical Science, 15, 133, 140"},{"key":"10.1054\/blre.1999.0116_RF38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand Disease with a new analyser using high shear stress: A study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF39","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V77.12.2547.2547","article-title":"The bleeding time does not predict surgical bleeding","volume":"77","author":"Lind","year":"1991","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF40","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood.V84.10.3363.3363","article-title":"Bleeding time and bleeding: An analysis of the relationship of the bleeding time test with parameters of surgical bleeding","volume":"84","author":"Caterina","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF41","article-title":"Platelet function testing","author":"Hutton","year":"1989","journal-title":"Association of Clinical Pathologists. Broadsheet 122; August"},{"key":"10.1054\/blre.1999.0116_RF42","first-page":"106","article-title":"Description of an in-vitro platelet function analyser: PFA-100TM","volume":"(Suppl 2) 21","author":"Kundu","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.1999.0116_RF43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0032-1313613","article-title":"Preliminary data from a field trial of the PFA-100TMsystem","volume":"21","author":"Mammen","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.1999.0116_RF44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/107602969600200404","article-title":"Characterisation of an in-vitro Platelet Function Analyser, PFA-100TM","volume":"2","author":"Kundu","year":"1996","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1054\/blre.1999.0116_RF45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<165::AID-AJH6>3.0.CO;2-C","article-title":"Screening for von Willebrand\u2019s disease: Use of a novel Platelet Function Analyser (PFA-100TM) with high sensitivity to disturbances in von Willebrand factor","volume":"62","author":"Favaloro","year":"1999","journal-title":"Am J Hematology"},{"key":"10.1054\/blre.1999.0116_RF46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1182\/blood.V95.1.164","article-title":"Structure and Function of the von Willebrand Factor A1 Domain. Analysis With Monoclonal Antibodies Reveals Distinct Binding Sites Involved in Recognition of the Platelet Membrane Glycoprotein Ib-IX-V Complex and Ristocetin-dependent Activation","volume":"95","author":"De Luca","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF47","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0049-3848(98)00163-7","article-title":"The Xylum Clot Signature Analyser: A dynamic flow system that simulates vascular injury","volume":"92","author":"Li","year":"1998","journal-title":"Throm Res"},{"key":"10.1054\/blre.1999.0116_RF48","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1055\/s-0037-1614375","article-title":"Laboratory testing for von Willebrand\u2019s disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey","volume":"82","author":"Favaloro","year":"1999","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1054\/blre.1999.0116_RF49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0037-1614468","article-title":"A new automated method for von Willebrand factor antigen measurement using latex particles","volume":"81","author":"Veyradier","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.1999.0116_RF50","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1097\/00001721-199706000-00001","article-title":"Evaluation of a new automated ELISA test for von Willebrand factor using two monoclonal antibodies","volume":"8","author":"Pittet","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1054\/blre.1999.0116_RF51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ajcp\/104.3.264","article-title":"Laboratory assessment of von Willebrand factor: Use of different assays can influence the diagnosis of von Willebrand\u2019s disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms","volume":"104","author":"Favaloro","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.1999.0116_RF52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0049-3848(98)00078-4","article-title":"von Willebrand factor: measuring its antigen of function? Correlation between the level of antigen, activity, and multimer size using various detection systems","volume":"91","author":"Fischer","year":"1998","journal-title":"Thromb Res"},{"key":"10.1054\/blre.1999.0116_RF53","first-page":"362","article-title":"Ristocetin. A new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thrombosis et Diathesis Haemorrhagica"},{"key":"10.1054\/blre.1999.0116_RF54","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1172\/JCI107465","article-title":"Quantitative assay of a plasma factor deficient in von Willebrand\u2019s Disease that is necessary for platelet aggregation","volume":"52","author":"Weiss","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1054\/blre.1999.0116_RF55","first-page":"306","article-title":"A method for assaying von Willebrand\u2019s factor (ristocetin cofactor)","volume":"34","author":"MacFarlane","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1054\/blre.1999.0116_RF56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/107602969700300208","article-title":"Laboratory assessment of von Willebrand factor: Altered interpretation of laboratory data, and altered diagnosis of von Willebrand\u2019s disease, as influenced by the use of different VWF assays and assay conditions","volume":"3","author":"Favaloro","year":"1997","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1054\/blre.1999.0116_RF57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1985.tb07350.x","article-title":"An immunoradiometric assay for human factor VIII von Willebrand factor (VIII:VWF) using a monoclonal antibody based that defines a functional epitope","volume":"59","author":"Goodall","year":"1985","journal-title":"Br J Haem"},{"key":"10.1054\/blre.1999.0116_RF58","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0038-1661555","article-title":"A two-site, monoclonal antibody based immunoassay for von Willebrand factor- Demonstration that VWF function resides in a conformational epitope","volume":"55","author":"Chand","year":"1986","journal-title":"Thromb Haemostas"},{"key":"10.1054\/blre.1999.0116_RF59","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the Ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thromb Haemostas"},{"key":"10.1054\/blre.1999.0116_RF60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1055\/s-0037-1615375","article-title":"Assays for von Willebrand Factor Functional Activity: A UK NEQAS Survey","volume":"80","author":"Preston","year":"1998","journal-title":"Thromb Haemostas"},{"key":"10.1054\/blre.1999.0116_RF61","article-title":"Collagen binding assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source","volume":"83","author":"Favaloro","year":"2000","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1054\/blre.1999.0116_RF62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Throm Res"},{"key":"10.1054\/blre.1999.0116_RF63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001721-199104000-00011","article-title":"Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand\u2019s disease","volume":"2","author":"Favaloro","year":"1991","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1054\/blre.1999.0116_RF64","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/00313029309084791","article-title":"von Willebrand\u2019s Disease: Laboratory investigation using an improved functional assay for von Willebrand factor","volume":"25","author":"Favaloro","year":"1993","journal-title":"Pathology"},{"key":"10.1054\/blre.1999.0116_RF65","first-page":"1160","article-title":"Characterisation of plasma-derived and recombinant human VWF by improved collagen binding assays","volume":"73","author":"Siekmann","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.1999.0116_RF66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(96)00161-2","article-title":"Effect of multimerisation of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII","volume":"84","author":"Fischer","year":"1996","journal-title":"Throm Res"},{"key":"10.1054\/blre.1999.0116_RF67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-2143(97)90147-5","article-title":"Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers","volume":"129","author":"Casonato","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1054\/blre.1999.0116_RF68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/biol.1998.0127","article-title":"Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay","volume":"26","author":"Ramasamy","year":"1998","journal-title":"Biologicals"},{"key":"10.1054\/blre.1999.0116_RF69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcp\/111.3.418","article-title":"Binding of von Willebrand Factor to Collagen by Flow Cytometry","volume":"111","author":"Kempfer","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.1999.0116_RF70","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1055\/s-0038-1660152","article-title":"Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the FVIII and von Willebrand factor subcommittee","volume":"54","author":"Mannuci","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.1999.0116_RF71","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0049-3848(92)90050-K","article-title":"Multimeric analysis of von Willebrand factor by vertical sodium docecyl sulphate agarose gel electrophoresis, vacuum blotting technology and sensitive visualisation by alkaline phosphatase anti-alkaline phosphatase complex","volume":"66","author":"Baillod","year":"1992","journal-title":"Thromb Res"},{"key":"10.1054\/blre.1999.0116_RF72","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcp\/109.3.347","article-title":"The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications","volume":"109","author":"Casonato","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.1999.0116_RF74","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand\u2019s disease: variability versus \u2018variants\u2019","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.2830400208","article-title":"On laboratory problems in diagnosing mild von Willebrand\u2019s Disease","volume":"40","author":"Blomback","year":"1992","journal-title":"A J Hematol"},{"key":"10.1054\/blre.1999.0116_RF76","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2516.1996.tb00140.x","article-title":"Laboratory assessment of von Willebrand factor: differential influence of prolonged ambient temperature specimen storage on assay results","volume":"2","author":"Favaloro","year":"1996","journal-title":"Haemophilia"},{"key":"10.1054\/blre.1999.0116_RF77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.2830450303","article-title":"von Willebrand\u2019s Disease: Use of collagen binding assay provides potential improvement to laboratory monitoring of Desmopressin (DDAVP) therapy","volume":"45","author":"Favaloro","year":"1994","journal-title":"Amer J Hematol"},{"key":"10.1054\/blre.1999.0116_RF78","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.88.14.6377","article-title":"Expression of von Willebrand factor \u2018Normandy\u2019: An autosomal mutation that mimics as hemophilia A","volume":"88","author":"Tuley","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/blre.1999.0116_RF79","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V78.9.2310.2310","article-title":"The binding of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673","volume":"78","author":"Christophe","year":"1991","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0116_RF80","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/S0021-9258(17)35782-4","article-title":"von Willebrand factor binds specifically to sulfated glycolipids","volume":"261","author":"Roberts","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1054\/blre.1999.0116_RF81","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2141.1999.01358.x","article-title":"Identification and characterisation of a novel mutation in von Willebrand Factor causing a Type 2B von Willebrand\u2019s Disease","volume":"105","author":"Facey","year":"1999","journal-title":"Br J Haematol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X99901169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X99901169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T07:05:50Z","timestamp":1621148750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X99901169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0268960X99901169"],"URL":"https:\/\/doi.org\/10.1054\/blre.1999.0116","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}